Testing effectiveness (Phase 2)Study completedNCT00621855
What this trial is testing
RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome
Who this might be right for
Coronary Disease
Boehringer Ingelheim 1,878